Antibody Junctional Diversity Explained
Junctional diversity is a crucial mechanism that significantly expands the repertoire of antibody molecules an individual can produce. This diversity arises during the process of V(D)J recombination in developing B cells.
Mechanism of Junctional Diversity
The primary source of junctional diversity stems from the random addition of nucleotides at the junctions where antibody gene segments (V, D, and J) are joined together.
- V(D)J Recombination: Developing B cells assemble functional immunoglobulin (antibody) genes by joining Variable (V), Diversity (D - in heavy chain only), and Joining (J) gene segments.
- Nucleotide Addition: During this joining process, the enzyme terminal deoxynucleotidyl transferase (TdT) can randomly add non-template nucleotides, known as N (nucleotide) regions. Additionally, processing of the DNA ends can expose palindromic sequences (P regions).
- Result: The imprecise joining, including the addition of N and P nucleotides, introduces variations at the V-D and D-J (or V-J) junctions. These variations lead to changes in the amino acid sequence, particularly in the complementary-determining regions (CDRs) of the antibody, creating a vast array of antigen-binding specificities.
Why Other Options Are Incorrect
- Switch region nucleotides: The addition or deletion of nucleotides in switch regions is associated with immunoglobulin class switching, not junctional diversity.
- Joining of V, D, and J segments: While the joining of these segments contributes to combinatorial diversity, the *junctional* diversity specifically comes from the modifications (N and P additions) occurring *at* these joining sites.
- Mutations in CDRs: Mutations in complementarity-determining regions (CDRs) refer to somatic hypermutation, a process occurring later that further refines antibody affinity but is distinct from the initial generation of junctional diversity.
Therefore, the addition of N and P nucleotides is the direct cause of junctional diversity in antibody molecules.